182 related articles for article (PubMed ID: 34882500)
1. Randomized Controlled Phase II Evaluation of Two Dose Levels of Bupropion Versus Placebo for Sexual Desire in Female Cancer Survivors: NRG-CC004.
Barton DL; Pugh SL; Ganz PA; Plaxe SC; Koontz BF; Carter J; Greyz-Yusupov N; Page SJ; Rowland KM; Balcueva EP; Nabeel S; Basil JB; Hill ML; Muller CY; Bell MC; Deshmukh S; Kachnic LA
J Clin Oncol; 2022 Feb; 40(4):324-334. PubMed ID: 34882500
[TBL] [Abstract][Full Text] [Related]
2. NRG-CC004 ancillary data study-exploring the effect of bupropion on sexual desire in female cancer survivors with and without vulvovaginal symptoms.
Carter J; Pugh SL; Arring N; Littell RD; Page SJ; Rowland KM; Goodman JR; Razaq W; Siddique S; Borges M; Kachnic LA; Barton DL
J Sex Med; 2024 Jun; ():. PubMed ID: 38856026
[TBL] [Abstract][Full Text] [Related]
3. The effects of the adjunctive bupropion on male sexual dysfunction induced by a selective serotonin reuptake inhibitor: a double-blind placebo-controlled and randomized study.
Safarinejad MR
BJU Int; 2010 Sep; 106(6):840-7. PubMed ID: 20067456
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled study of the efficacy and safety of bupropion for treating hypoactive sexual desire disorder in ovulating women.
Safarinejad MR; Hosseini SY; Asgari MA; Dadkhah F; Taghva A
BJU Int; 2010 Sep; 106(6):832-9. PubMed ID: 20151970
[TBL] [Abstract][Full Text] [Related]
5. Reversal of SSRI-induced female sexual dysfunction by adjunctive bupropion in menstruating women: a double-blind, placebo-controlled and randomized study.
Safarinejad MR
J Psychopharmacol; 2011 Mar; 25(3):370-8. PubMed ID: 20080928
[TBL] [Abstract][Full Text] [Related]
6. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.
Clayton AH; Croft HA; Horrigan JP; Wightman DS; Krishen A; Richard NE; Modell JG
J Clin Psychiatry; 2006 May; 67(5):736-46. PubMed ID: 16841623
[TBL] [Abstract][Full Text] [Related]
7. Sexual dysfunction associated with the treatment of depression: a placebo-controlled comparison of bupropion sustained release and sertraline treatment.
Coleman CC; Cunningham LA; Foster VJ; Batey SR; Donahue RM; Houser TL; Ascher JA
Ann Clin Psychiatry; 1999 Dec; 11(4):205-15. PubMed ID: 10596735
[TBL] [Abstract][Full Text] [Related]
8. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET Study.
Derogatis LR; Komer L; Katz M; Moreau M; Kimura T; Garcia M; Wunderlich G; Pyke R;
J Sex Med; 2012 Apr; 9(4):1074-85. PubMed ID: 22248038
[TBL] [Abstract][Full Text] [Related]
9. Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women.
Segraves RT; Clayton A; Croft H; Wolf A; Warnock J
J Clin Psychopharmacol; 2004 Jun; 24(3):339-42. PubMed ID: 15118489
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of flibanserin in women with hypoactive sexual desire disorder: results from the BEGONIA trial.
Katz M; DeRogatis LR; Ackerman R; Hedges P; Lesko L; Garcia M; Sand M;
J Sex Med; 2013 Jul; 10(7):1807-15. PubMed ID: 23672269
[TBL] [Abstract][Full Text] [Related]
11. A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline.
Croft H; Settle E; Houser T; Batey SR; Donahue RM; Ascher JA
Clin Ther; 1999 Apr; 21(4):643-58. PubMed ID: 10363731
[TBL] [Abstract][Full Text] [Related]
12. Bupropion sustained release (SR) for the treatment of hypoactive sexual desire disorder (HSDD) in nondepressed women.
Segraves RT; Croft H; Kavoussi R; Ascher JA; Batey SR; Foster VJ; Bolden-Watson C; Metz A
J Sex Marital Ther; 2001; 27(3):303-16. PubMed ID: 11354935
[TBL] [Abstract][Full Text] [Related]
13. Effect of long-term intranasal oxytocin on sexual dysfunction in premenopausal and postmenopausal women: a randomized trial.
Muin DA; Wolzt M; Marculescu R; Sheikh Rezaei S; Salama M; Fuchs C; Luger A; Bragagna E; Litschauer B; Bayerle-Eder M
Fertil Steril; 2015 Sep; 104(3):715-23.e4. PubMed ID: 26151620
[TBL] [Abstract][Full Text] [Related]
14. Dose-Finding Study of Lorexys for Hypoactive Sexual Desire Disorder in Premenopausal Women.
Pyke RE; Clayton AH
J Sex Med; 2019 Dec; 16(12):1885-1894. PubMed ID: 31678098
[TBL] [Abstract][Full Text] [Related]
15. A placebo-controlled, randomized, double-blind study of adjunctive bupropion sustained release in the treatment of SSRI-induced sexual dysfunction.
DeBattista C; Solvason B; Poirier J; Kendrick E; Loraas E
J Clin Psychiatry; 2005 Jul; 66(7):844-8. PubMed ID: 16013899
[TBL] [Abstract][Full Text] [Related]
16. Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder: Results of the PLUMERIA Study.
Portman DJ; Brown L; Yuan J; Kissling R; Kingsberg SA
J Sex Med; 2017 Jun; 14(6):834-842. PubMed ID: 28583342
[TBL] [Abstract][Full Text] [Related]
17. Flibanserin for Hypoactive Sexual Desire Disorder: An Open-Label Safety Study.
Simon JA; Derogatis L; Portman D; Brown L; Yuan J; Kissling R
J Sex Med; 2018 Mar; 15(3):387-395. PubMed ID: 29502984
[TBL] [Abstract][Full Text] [Related]
18. Individual and dyadic barriers to a pharmacotherapeutic treatment of hypoactive sexual desire disorders: results and implications from a small-scale study with bupropion.
Hartmann UH; Rüffer-Hesse C; Krüger TH; Philippsohn S
J Sex Marital Ther; 2012; 38(4):325-48. PubMed ID: 22712818
[TBL] [Abstract][Full Text] [Related]
19. Sexual function remains persistently low in women after treatment for colorectal cancer and anal squamous cell carcinoma.
Savoie MB; Paciorek A; Van Loon K; Anwar M; Atreya CE; Johnson PC; Kenfield SA; Laffan A; Levin AO; Smith JF; Stanfield D; Venook A; Zhang L; Van Blarigan EL; Rowen T
J Sex Med; 2023 Mar; 20(4):439-446. PubMed ID: 36805959
[TBL] [Abstract][Full Text] [Related]
20. Sustained-release bupropion for selective serotonin reuptake inhibitor-induced sexual dysfunction: a randomized, double-blind, placebo-controlled, parallel-group study.
Masand PS; Ashton AK; Gupta S; Frank B
Am J Psychiatry; 2001 May; 158(5):805-7. PubMed ID: 11329407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
